FNY Investment Advisers LLC Makes New Investment in M3-Brigade Acquisition V Corp. $MBAV

FNY Investment Advisers LLC acquired a new stake in M3-Brigade Acquisition V Corp. (NASDAQ:MBAV) in the third quarter, HoldingsChannel reports. The institutional investor acquired 158,500 shares of the company’s stock, valued at approximately $1,672,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Polar Asset Management Partners Inc. boosted its position in shares of M3-Brigade Acquisition V by 64.3% during the 3rd quarter. Polar Asset Management Partners Inc. now owns 1,200,005 shares of the company’s stock valued at $12,660,000 after acquiring an additional 469,678 shares in the last quarter. Cantor Fitzgerald L. P. increased its stake in M3-Brigade Acquisition V by 836.2% in the third quarter. Cantor Fitzgerald L. P. now owns 154,338 shares of the company’s stock valued at $1,628,000 after acquiring an additional 137,853 shares during the period. Heights Capital Management Inc. acquired a new position in M3-Brigade Acquisition V in the third quarter worth about $5,275,000. Meteora Capital LLC raised its position in M3-Brigade Acquisition V by 133.0% in the third quarter. Meteora Capital LLC now owns 1,475,801 shares of the company’s stock worth $15,570,000 after purchasing an additional 842,418 shares in the last quarter. Finally, Whitebox Advisors LLC lifted its stake in M3-Brigade Acquisition V by 18.2% during the third quarter. Whitebox Advisors LLC now owns 130,000 shares of the company’s stock worth $1,372,000 after purchasing an additional 20,000 shares during the period.

M3-Brigade Acquisition V Stock Performance

Shares of NASDAQ:MBAV opened at $10.70 on Thursday. The company’s fifty day moving average is $10.68 and its 200-day moving average is $10.63. M3-Brigade Acquisition V Corp. has a 52 week low of $10.19 and a 52 week high of $13.73.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on MBAV shares. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of M3-Brigade Acquisition V in a report on Monday, December 22nd. Wall Street Zen raised M3-Brigade Acquisition V to a “sell” rating in a report on Saturday, March 14th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock currently has an average rating of “Sell”.

M3-Brigade Acquisition V Profile

M3-Brigade Acquisition V is a special purpose acquisition company (SPAC) sponsored by M3 Inc, a global healthcare information and technology provider, and Brigade Capital Management, an investment management firm. The company is structured as a blank‐check vehicle listed on the Nasdaq Stock Market under the ticker MBAV, with the objective of identifying and completing a business combination in the healthcare, life sciences or related sectors.

The company benefits from the operational expertise of M3’s digital health platform and real‐world data capabilities, combined with Brigade’s deep experience in credit and asset management.